Levetiracetam monotherapy for seizure control in an HIV population

Seizures represent a manifestation of nervous system involvement that is common among patients infected with human immunodeficiency virus (HIV), with a reported frequency rate ranging from 3-11 % (1,2). This rate is higher than the 1-2 % frequency reported in the general population (3). In patients infected with HIV, the seizure recurrence rate can be as high as 70 % (4), warranting earl